A strategic advisor and thought-leader on transforming hearing healthcare, Nancy M. Williams is founder and president of Auditory Insight. Ms. Williams partners with senior executives of pharma and device companies to develop successful commercialization strategies in hearing healthcare. She also advises growth equity and private equity firms to create portfolio value in hearing healthcare. Her clients span all sectors of hearing healthcare, from hearing aids to tinnitus treatments to drug and gene therapies. Ms. Williams leverages her deep insight into consumer needs and experience, practical understanding of clinical behaviors of audiologists and ENTs, and unique viewpoints on how hearing healthcare is evolving. Personally informing her work is her genetic hearing loss. She holds an MBA from Harvard Business School and a BA from Stanford University in Quantitative Economics, both with distinction.
Apple’s new Loud Sound Reduction capability scans the environment 46,000 times a second for sudden peaks in sound, reducing them to a safe level.
The preliminary results from three clinical trials administering gene therapy to address deafness from otoferlin mutations mark inspiring and incredible progress in hearing healthcare.
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
A hearing healthcare veteran consultant, who has significant hearing loss, describes 7 market-tested best practices. Understanding the consumer-patient journey is crucial to developing strategic priorities for companies across hearing healthcare, from hearing aids to cochlear implants to gene/drug therapy.
Some patients recognize no words at all 12 months after surgery, while others essentially have normal hearing in our analysis. This wide range of speech perception outcomes, we conclude, translates into considerable uncertainty for patients.
Strategies for combating the infiltration of a set of societal beliefs that leads to poor health outcomes is what makes anti-smoking campaigns a compelling analog on the eve of a new OTC hearing aid category.
An overlooked yet central aspect of Apple’s solution is that the AirPods Pro now integrates customized amplification with hearing protection against noise in a single device.
When it comes to managing inbound phone calls, underperformance has devastating cost implications.
With hearing loss considered to be a social determinant of health, Medicare Advantage payers have taken a more comprehensive approach to hearing healthcare over the last five years. And in turn device makers have responded.
Once the FDA finalizes guidelines, the six global hearing aid companies will face a trajectory familiar to other sectors that have shifted to OTC in the past. They will likely confront dramatically lower prices but also the opportunity to develop the larger market
An important trend contributing to the consumerization of healthcare is the transformation of select prescription categories to over-the-counter.
Hearables point to the potential convergence of traditional hearing aids with consumer product audio devices.
Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.
Now that President Trump has signed the Over-The-Counter Hearing Aid Act into law, hearing companies are advancing towards the starting blocks for what's shaping up to be a new race to solve hearing loss.